Market Closed - 07:55:03 31/10/26 am AEDT 5-day change 1st Jan Change
0.003000 EUR -.--% Intraday chart for MagForce AG -.--% +50.00%
6 months-14.29%
Current year+50.00%
1 month+50.00%
6 months-14.29%
Current year+50.00%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.001
0.02
1 year 0
Extreme 0.001
0.02
3 years 0
Extreme 0.0002
0.02
5 years 0
Extreme 0.0002
0.02
10 years 0
Extreme 0.0002
0.02
Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 55 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/12/20 Buy

Chief Executive Officer

250,000 0.9045%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+50.00%+25.00% 102K
-0.62%-1.87%+42.87%+64.15% 63.77B
+0.35%+3.20%+14.40%+81.76% 56.37B
+0.53%+1.96%+16.24%+103.35% 54.62B
-2.81%-4.31%+23.50%+47.83% 44.06B
-0.33%-1.93%+19.28%+98.80% 42.11B
+0.55%+2.31%+225.14%+866.21% 41B
+3.27%+47.96%+112.84%+96.58% 34.92B
+1.22%-1.44%+14.57%+46.95% 32.82B
+0.89%+20.55%-40.62%+349.24% 24.7B
Average +0.31%+6.79%+47.82%+177.99% 39.43B
Weighted average by Cap. +0.18%+5.44%+47.99%+176.67%

Financials

2020 2021
Net sales 1.5M 1.68M 1.38M 1.25M 2.34M 159M 2.38M 16.48M 6.62M 83.78M 6.3M 6.16M 264M 1.08M 1.2M 991K 898K 1.68M 114M 1.71M 11.82M 4.74M 60.07M 4.51M 4.42M 189M
Net income 14.75M 16.47M 13.56M 12.29M 22.97M 1.56B 23.4M 162M 64.94M 822M 61.79M 60.48M 2.59B -10.57M -11.81M -9.73M -8.81M -16.47M -1.12B -16.78M -116M -46.56M -590M -44.31M -43.37M -1.86B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33
Date Price Change Volume
30/10/26 EUR 0.003000 -.--% 1,500
29/10/26 EUR 0.003000 -.--% 0
28/10/26 EUR 0.003000 -.--% 475
27/10/26 EUR 0.003000 -.--% 50
26/10/26 EUR 0.003000 -.--% 2,750